Genprex, Inc.
USD0.52
+0.01 (+2.77%)
CEO
Ryan Confer
IPO Date
2018-03-29
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$0.51
Prev. Close
$0.51
Day Low
$0.49
Day High
$0.52
52W Low
$0.42
52W High
$55.00
Market Cap
$0.00B
Volume
0.16M
| 10 |
| $1.23 |
| 27 Feb 2026 | Berger Mark Stanley | Chief Medical Officer | F-InKind | Disposed | 7,168 | $2.00 |
| 27 Feb 2026 | Confer Ryan M. | director, officer: President, CEO and CFO | F-InKind | Disposed | 9,330 | $2.00 |
| 23 Dec 2025 | Moreno Toscano Jose Antonio | director | A-Award | Acquired | 9,000 | $0.00 |
| 23 Dec 2025 | Berger Mark Stanley | Chief Medical Officer | A-Award | Acquired | 28,500 | $0.00 |
| 23 Dec 2025 | Confer Ryan M. | director, officer: President, CEO and CFO | A-Award | Acquired | 45,000 | $0.00 |
| 23 Dec 2025 | LONGNECKER BRENT M | director | A-Award | Acquired | 9,000 | $0.00 |
| 23 Dec 2025 | Wilson William R Jr. | director | A-Award | Acquired | 9,000 | $0.00 |
| 1 Jul 2025 | Berger Mark Stanley | Chief Medical Officer | F-InKind | Disposed | 4,500 | $0.23 |
| 8 Jan 2026 | Tim Moore | Tim Moore | Purchase | $1,001 - $15,000 |
| 3 Dec 2025 | Tim Moore | Tim Moore | Purchase | $1,001 - $15,000 |